2005•European Journal of Drug Metabolism and PharmacokineticsRequires access

Assessment of oral bioavailability and preclinical pharmacokinetics of DRF-6196, a novel oxazolidinone analogue, in comparison to linezolid®

Ravikanth Bhamidipati, P Venkatesh, Prajakta V. Dravid, Prasad C. Narasimhulu, Sastry Tvrs, Jagattaran Das, Ramesh Mullangi, N. R. Srinivas

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Pharmacokinetics, Bioavailability, Cmax, Dosing, Pharmacology, Oral administration, Linezolid, Volume of distribution

Back to paper search Browse research topics Original source

Assessment of oral bioavailability and preclinical pharmacokinetics of DRF-6196, a novel oxazolidinone analogue, in comparison to linezolid® — Research Paper | ScholarLens